Format

Send to

Choose Destination
Ann Thorac Med. 2014 Jul;9(Suppl 1):S1-S15. doi: 10.4103/1817-1737.134006.

Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.

Author information

1
Department of Pulmonary Medicine, Price Sultan Military Medical City, Riyadh, Saudi Arabia.
2
Department of Pulmonary Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
3
Department of Critical Care Medicine, King Fahd Medical Center, Dammam, Saudi Arabia.
4
Department of Pulmonary and Critical Care Medicine, King Fahd Medical City, Riyadh, Saudi Arabia.
5
Department of Pulmonary Medicine, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
6
Department of Pulmonary Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
7
Department of Pediatric, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
8
Department of Congenital Heart Disease, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
9
Department of Cardiology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
10
Department of Organ Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
11
Department of Pediatric Cardiology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
12
Department of Pediatric Intensive Care, Price Sultan Military Medical City, Riyadh, Saudi Arabia.
13
Department of Pediatric Cardiology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
14
Department of Pediatric, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
15
Department of Cardiac Science, King Khalid University Hospital, Riyadh, Saudi Arabia.
16
Department of Heart Institute, University of São Paulo Medical School, São Paulo, Brazil.
17
Respiratory Institute, Cleveland Clinic, Ohio, USA.
18
Pulmonary Hypertension Program, Johns Hopkins University, Baltimore, Maryland, USA.
19
Department of CSIR-Institute of Genomics and Integrative Biology, Delhi, India.
20
Department of Thoracic Surgery, Kerckhoff Clinic, Bad Nauheim, Germany.
21
Department of Cardiopulmonary science, Imperial College, London, UK.
22
Department of Cardiology section, CARE Hospital, Hyderabad, India.
23
Department of Fondazione IR IRCCS Policlinico San Matteo, Pavia, Italy.
24
Department of Pulmonary Medicine, University of British Columbia, Vancouver, BC, Canada.
25
Department of Pulmonary Hypertension Program, Hanover Medical School, Hanover, Germany.

Abstract

The Saudi Association for Pulmonary Hypertension (previously called Saudi Advisory Group for Pulmonary Hypertension) has published the first Saudi Guidelines on Diagnosis and Treatment of Pulmonary Arterial Hypertension back in 2008.[1] That guideline was very detailed and extensive and reviewed most aspects of pulmonary hypertension (PH). One of the disadvantages of such detailed guidelines is the difficulty that some of the readers who just want to get a quick guidance or looking for a specific piece of information might face. All efforts were made to develop this guideline in an easy-to-read form, making it very handy and helpful to clinicians dealing with PH patients to select the best management strategies for the typical patient suffering from a specific condition. This Guideline was designed to provide recommendations for problems frequently encountered by practicing clinicians involved in management of PH. This publication targets mainly adult and pediatric PH-treating physicians, but can also be used by other physicians interested in PH.

KEYWORDS:

Pulmonary hypertension; SAPH guidelines; modified functional class; pulmonary vascular resistance; target therapy

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center